Fundraising Fox
Intervacc
Stockholm, SE · 1 known investors
Find your way into Intervacc
Sign up to see every warm intro you have to Intervacc
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Intervacc team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Intervacc develops veterinary vaccines based on recombinant protein fusions. The company's lead product, Strangvac®, prevents strangles in horses, a serious and contagious global disease, and is available on several major European markets.
Founders & leadership
Investors · 1
Frequently asked questions
- What does Intervacc do?
- Intervacc develops veterinary vaccines based on recombinant protein fusions. The company's lead product, Strangvac®, prevents strangles in horses, a serious and contagious global disease, and is available on several major European markets.
- Who are Intervacc's investors?
- Intervacc's investors include HealthCap.
- Where is Intervacc headquartered?
- Intervacc is headquartered in Stockholm, SE.